sena güzel karahan

Mrs. sena güzel karahan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
PDF file
MDMefküre Durmuş
Mefküre Durmuş
SKSerkan Kalkan
Serkan Kalkan
SKsena güzel karahan
sena güzel karahan
MBMurat Biçakcioğlu
Murat Biçakcioğlu
NÖNesligül Özdemir
Nesligül Özdemir
AÖAyşe Belin Özer
Ayşe Belin Özer
Background Candidemia is an opportunistic infection of intensive care units (ICUs) and causes morbidity and mortality. Multiple antibiotic exposure was found to be an independent risk factor for mortality and non-albicans candidemia (NAC) in candidemia patients. Aim The aim of this study was to determine the relationship between antibiotics and clinical features of patients with candidemia, and to determine the independent risk factors for hospital stay >50 days, 30-day mortality in hospital, candidemia types, and septic shock in candidemia patients. Methods Patients were evaluated retrospectively for 5 years. A total of 148 candidemia cases were detected and included in the study. Characteristics of cases were defined and recorded. The relationship between qualitative data was determined by the χ2 test. Logistic regression analysis was used to determine the independent risk factors for hospital stay >50 days, 30-day mortality in hospital, candidemia types, and septic shock in candidemia patients. Results The incidence of candidemia for 5 years was 4.5%. Candida parapsilosis was the most reported species with 65% (n=97). Linezolid and central venous catheters (CVC) were found to be independent risk factors for NAC. Carbapenems and cephalosporins were found in association to lower mortality. No antibiotics or characteristics were found to be independent risk factors for mortality. Some broad spectrum antibiotics and antibiotic combinations were found in relationship with hospital stay >50 days; however, none of them were found to be independent risk factors. Metisilin resistant staphylococcus aureus (MRSA) antibiotics, meropenem+linezolid piperacillin-tazobactam+fluoroquinolones and comorbidity were found in association with septic shock, although only piperacillin-tazobactam+fluoroquinolones and comorbidity were found to be independent risk factors for septic shock. Conclusions This study concluded that many antibiotics were safe for candidemia patients. However, clinicians should pay attention when prescribing linezolid or piperacillin-tazobactam and flouroquinolons concomitantly or sequentially for patients with candidemia risk factors.

1 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MDMefküre Durmuş
Mefküre Durmuş
SKsena güzel karahan
sena güzel karahan
Sami AkbulutSami Akbulut
Sami Akbulut
ZYZeynep Burcin Yilmaz
Zeynep Burcin Yilmaz
EKErtugrul Karabulut
Ertugrul Karabulut
Background: Liver transplant recipients are highly susceptible to invasive fungal infections, particularly candidemia, due to intensive immunosuppressive therapy and postoperative complications. However, few studies have comprehensively examined postoperative antimicrobial and immunosuppressive factors in this context. Aim: This study aimed to identify perioperative and postoperative factors associated with the development of candidemia in living donor liver transplant (LDLT) recipients, with a particular focus on antimicrobial and immunosuppressive regimens during initial hospitalization. Methods: A retrospective case–control analysis was conducted involving 36 LDLT recipients who developed candidemia (candidemia group) and 72 matched controls without candidemia (non-candidemia group) between January 2019 and November 2023. Demographic and clinical variables were compared using univariate and multivariate logistic regression analyses to identify independent associations. A post hoc power analysis demonstrated a high statistical power (97.3%) to detect large effect sizes. Results: Univariate analysis revealed significant associations with prolonged intubation (p < 0.001), bile leaks (p < 0.001), relaparotomy (p < 0.001), chronic renal disease (p = 0.011), hepatocellular carcinoma (p = 0.011), and the use of antimicrobials including meropenem (p = 0.048), linezolid (p = 0.005), tigecycline (p = 0.045), third-generation cephalosporins (p = 0.003), anidulafungin (p < 0.001), fluconazole (p = 0.006), mycophenolate (p = 0.011), and total parenteral nutrition (TPN) (p = 0.049). CMV prophylaxis (p < 0.001) and CMV-PCR positivity (p = 0.015) were also significantly associated with candidemia. Multivariate logistic regression analysis identified prolonged intubation (OR = 1.07; p = 0.019), bile leaks (OR = 10.9; p = 0.002), anidulafungin use (OR = 4.70; p = 0.032), fluconazole use (OR = 35.8; p = 0.005), and absence of CMV prophylaxis (OR = 11.7; p = 0.021) as independent factors associated with increased odds of candidemia. Conclusions: Prolonged intubation, bile leaks, antifungal exposure, and lack of CMV prophylaxis are independently associated with higher odds of candidemia after LDLT. Targeted prophylaxis, prudent antimicrobial stewardship, and timely biliary intervention may reduce fungal morbidity and mortality in post-transplant patients.

30 December 2025 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
BDBülent Dertli
Bülent Dertli
SKsena güzel karahan
sena güzel karahan
KKKadir Köseoğlu
Kadir Köseoğlu
AÇAhmet Çakır
Ahmet Çakır
ESEkrem Salduz
Ekrem Salduz
Viral encephalitis is a hazardous central nervous system disorder requiring immediate antiviral intervention. Acyclovir is the standard treatment for herpes simplex virus (HSV) encephalitis; nevertheless, improper dosing or administration can lead to nephrotoxicity and neurotoxicity. This case describes a 54-year-old male patient admitted for an allergic reaction, who thereafter had incoherent speech, instability and involuntary motions suggestive of HSV encephalitis. Intravenous acyclovir treatment was initiated empirically following cerebrospinal fluid examination. On the third day of therapy, the patient exhibited acute renal impairment, accompanied by hallucinations and significant psychomotor agitation. Following the clinical pharmacist's recommendations, the dosage was adjusted and the infusion period was prolonged to at least 1 hour, predicated on an estimated glomerular filtration rate of 20 mL/min/1,73 m². Subsequent to these surgeries, renal function and neurological status steadily enhanced, enabling a successful resolution of treatment. This example highlights the crucial role of clinical pharmacists in reducing acyclovir-related toxicities via personalised dosage and infusion management.

27 November 2025
Verified
Book Chapter
Open access
PDF file
KKKadir Köseoğlu
Kadir Köseoğlu
SKsena güzel karahan
sena güzel karahan
Metabolik hastalıklar, günümüzde küresel ölçekte önemli bir halk sağlığı yükü oluşturmaktadır. Özellikle tip 2 diyabet ve obezite, insülin direnci, glikoz homeostazındaki bozulmalar ve inflamatuvar süreçlerle ilişkili çok faktörlü patofizyolojiye sahiptir. Bu hastalıkların tedavisinde kullanılan geleneksel ajanların sınırlı etkinliği ve güvenlik endişeleri, yeni farmakoterapötik yaklaşımların geliştirilmesini zorunlu kılmıştır. Bu bağlamda inkretin temelli tedavilerin önemli bileşeni olan glukagon benzeri peptid-1 (GLP-1) reseptör agonistleri klinik uygulamada giderek daha fazla yer bulmaktadır. GLP-1 reseptör agonistleri, glisemik kontrolü iyileştirmenin yanı sıra glukagon sekresyonunu baskılamakta, gastrik boşalmayı yavaşlatmakta ve iştahı azaltarak kilo kaybına katkı sağlamaktadır. Kardiyovasküler ve renal koruyucu etkileri de kanıtlanmış olup, majör advers kardiyovasküler olayların sıklığını azaltmaktadır. Klinik kullanıma sunulan eksenatid, liraglutid, semaglutid, dulaglutid ve tirzepatid gibi ajanlar farklı farmakokinetik özellikler sergilemektedir. Ayrıca obezite, ateroskleroz ve hipertansiyon yönetiminde de etkinlik göstermeleri kullanım alanlarını genişletmiştir. Bununla birlikte gastrointestinal yan etkiler ve maliyet gibi sınırlayıcı faktörler tedaviye uyumu etkileyebilmektedir. Gelecekte yapılacak araştırmalar, oral formülasyonlar ve çoklu agonist kombinasyonlarıyla etkinlik ve güvenliği artırmaya odaklanmalıdır.

3 September 2025 in Anatolian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SKsena güzel karahan
sena güzel karahan
NANesligül Özdemir Ayduran
Nesligül Özdemir Ayduran
MDMefküre Durmuş
Mefküre Durmuş
ŞGŞükrü Güngör
Şükrü Güngör
FVFATMA İLKNUR VAROL
FATMA İLKNUR VAROL
In this case report, we present a 2-year-old child who was treated with long-term meropenem infusion for multidrug-resistant (MDR) Klebsiella pneumoniae bacteraemia after liver transplantation. The patient underwent transplantation for Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2). MDR Klebsiella pneumoniae was detected in blood cultures on the 18th postoperative day. Since no clinical response was obtained to the empirical amikacin treatment, the treatment was switched to colistin and meropenem combination. Upon recurrence of the infection, meropenem was administered as a 3-hour long-term infusion by increasing the dose. Following this approach, significant clinical improvement was observed, with a marked decrease in inflammatory markers. Importantly, liver function tests remained stable throughout the treatment period. This case highlights that extended meropenem infusion may be a valuable therapeutic option in the management of MDR Gram-negative infections in paediatric liver transplant recipients and highlights its potential efficacy and safety in such high-risk patient populations.

22 October 2025
Verified
Book
Closed access
BABelgin Alaşehirli
Belgin Alaşehirli
ADAlgul Dilara Dokumaci
Algul Dilara Dokumaci
AAAres Alizade
Ares Alizade
ASAyça Toprak Semiz
Ayça Toprak Semiz
MOMert C. Ongun
Mert C. Ongun
EHEylül Haravı
Eylül Haravı
Farmakoloji, mode tıbbın bilimsel temellerinden birini oluşturan, ilaçların canlı sistemlerdeki etkilerini, etki mekanizmalarını ve terapötik uygulamalarını inceleyen temel bir bilim dalıdır. Günümüzde farmakolojinin çalışma alanı, klasik farmasötik ve fizyolojik sınırların ötesine geçerek, moleküler biyoloji, genetik, biyoteknoloji, nanoteknoloji ve yapay zekâ gibi çok sayıda bilim dalıyla etkileşim hâlindedir. Farmakoloji Alanında Güncel Yaklaşımlar, bu çok yönlü yapıyı bilimsel bir bütünlük içinde ele alarak, hem temel hem de klinik farmakolojiye ilişkin güncel bilgileri akademik düzeyde sunmaktadır. Alanında uzman akademisyenlerin katkılarıyla hazırlanan bu eser, farmakoloji biliminin güncel gelişmelerini bilimsel temelleriyle birlikte değerlendiren, hem araştırmacılar hem de lisansüstü düzeydeki öğrenciler için başvuru niteliğinde bir kaynaktır. Kitap, farmakolojinin hızla ilerleyen bilgi birikimine katkı sağlamayı, yeni araştırma perspektifleri sunmayı ve farmakolojinin geleceğine ışık tutmayı hedeflemektedir.